34 min listen
Preparing For The Clinic With Amolyt Pharma CEO Dr. Thierry Abribat
Preparing For The Clinic With Amolyt Pharma CEO Dr. Thierry Abribat
ratings:
Length:
36 minutes
Released:
Mar 8, 2021
Format:
Podcast episode
Description
Amolyt Pharma is developing a therapeutic peptide program targeting rare endocrine and metabolic diseases including hypoparathyroidism and acromegaly. Fresh on the heels of its lead candidate's foray into phase 1 clinical trials, we're joined by the company's founder and CEO, Thierry Abribat, Ph.D., for a deep dive into Amolyt Pharma's pre-clinical preparation, including his financing, talent acquisition, and clinical study strategies.
Released:
Mar 8, 2021
Format:
Podcast episode
Titles in the series (100)
Summer Sessions 6: Alexis Peyroles On Myeloid Cells, Transplants, & Immuno-Oncology Inspiration by Business Of Biotech